These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26657456)

  • 21. Acute and chronic pouchitis--pathogenesis, diagnosis and treatment.
    Shen B
    Nat Rev Gastroenterol Hepatol; 2012 Apr; 9(6):323-33. PubMed ID: 22508158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome of biological therapies in chronic antibiotic-refractory pouchitis: A retrospective single-centre experience.
    Verstockt B; Claeys C; De Hertogh G; Van Assche G; Wolthuis A; D'Hoore A; Vermeire S; Ferrante M
    United European Gastroenterol J; 2019 Nov; 7(9):1215-1225. PubMed ID: 31700634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predominantly Antibiotic-resistant Intestinal Microbiome Persists in Patients With Pouchitis Who Respond to Antibiotic Therapy.
    Dubinsky V; Reshef L; Bar N; Keizer D; Golan N; Rabinowitz K; Godny L; Yadgar K; Zonensain K; Tulchinsky H; Gophna U; Dotan I
    Gastroenterology; 2020 Feb; 158(3):610-624.e13. PubMed ID: 31605691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Faecal M2-pyruvate kinase: a novel, noninvasive marker of ileal pouch inflammation.
    Johnson MW; Maestranzi S; Duffy AM; Dewar DH; Ciclitira PJ; Sherwood RA; Nicholls JR
    Eur J Gastroenterol Hepatol; 2009 May; 21(5):544-50. PubMed ID: 19300275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical implication of false-positive celiac serology in patients with ileal pouch.
    Lian L; Remzi FH; Kiran RP; Fazio VW; Shen B
    Dis Colon Rectum; 2010 Oct; 53(10):1446-51. PubMed ID: 20847628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies against glycoprotein 2 are novel markers of intestinal inflammation in patients with an ileal pouch.
    Werner L; Sturm A; Roggenbuck D; Yahav L; Zion T; Meirowithz E; Ofer A; Guzner-Gur H; Tulchinsky H; Dotan I
    J Crohns Colitis; 2013 Dec; 7(11):e522-32. PubMed ID: 23639628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extended spectrum beta-lactamase-producing bacteria and Clostridium difficile in patients with pouchitis.
    McLaughlin SD; Clark SK; Roberts CH; Perry-Woodford ZL; Tekkis PP; Ciclitira PJ; Nicholls RJ
    Aliment Pharmacol Ther; 2010 Sep; 32(5):664-9. PubMed ID: 20626734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful Treatment With Vedolizumab in a Patient With Chronic Refractory Pouchitis and Primary Sclerosing Cholangitis.
    Coletta M; Paroni M; Caprioli F
    J Crohns Colitis; 2017 Dec; 11(12):1507-1508. PubMed ID: 29106505
    [No Abstract]   [Full Text] [Related]  

  • 29. Suppurative granulomatous inflammation in the ileo-anal pouch.
    So K; Shepherd NA; Mandalia T; Ahmad T
    J Crohns Colitis; 2013 Jun; 7(5):e186-8. PubMed ID: 22824099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral budesonide in the treatment of chronic refractory pouchitis.
    Gionchetti P; Rizzello F; Poggioli G; Pierangeli F; Laureti S; Morselli C; Tambasco R; Calabrese C; Campieri M
    Aliment Pharmacol Ther; 2007 May; 25(10):1231-6. PubMed ID: 17451569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The therapeutic potential of antibiotics and probiotics in the treatment of pouchitis.
    Gionchetti P; Calabrese C; Lauri A; Rizzello F
    Expert Rev Gastroenterol Hepatol; 2015; 9(9):1175-81. PubMed ID: 26202437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical approach to diseases of ileal pouch-anal anastomosis.
    Shen B; Fazio VW; Remzi FH; Lashner BA
    Am J Gastroenterol; 2005 Dec; 100(12):2796-807. PubMed ID: 16393238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of Vedolizumab in Patients with Antibiotic and Anti-tumor Necrosis Alpha Refractory Pouchitis.
    Philpott J; Ashburn J; Shen B
    Inflamm Bowel Dis; 2017 Jan; 23(1):E5-E6. PubMed ID: 27930413
    [No Abstract]   [Full Text] [Related]  

  • 34. Faecal calprotectin: a noninvasive diagnostic tool and marker of severity in pouchitis.
    Johnson MW; Maestranzi S; Duffy AM; Dewar DH; Forbes A; Bjarnason I; Sherwood RA; Ciclitira P; Nicholls JR
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):174-9. PubMed ID: 18301296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoglobulin G4 (IgG4)-associated pouchitis - Part of IgG4 related disease? A case series and review of the literature.
    Bilal M; Gulati A; Clarke K
    Dig Liver Dis; 2016 Jul; 48(7):817-9. PubMed ID: 27038705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of orthotopic liver transplant for primary sclerosing cholangitis on chronic antibiotic refractory pouchitis.
    Freeman K; Shao Z; Remzi FH; Lopez R; Fazio VW; Shen B
    Clin Gastroenterol Hepatol; 2008 Jan; 6(1):62-8. PubMed ID: 18065274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pouchitis and pouch dysfunction.
    Wu H; Shen B
    Gastroenterol Clin North Am; 2009 Dec; 38(4):651-68. PubMed ID: 19913207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ustekinumab Rescue Therapy in a Patient With Chronic Refractory Pouchitis.
    Peter J; Zeitz J; Stallmach A
    J Crohns Colitis; 2018 Jul; 12(8):1008-1009. PubMed ID: 29659775
    [No Abstract]   [Full Text] [Related]  

  • 39. One year of infliximab therapy successfully improved a case of refractory pouchitis without the use of antibiotics.
    Iizuka M; Etou T; Yagisawa H; Ishii T; Sagara S
    Intern Med; 2014; 53(22):2581-3. PubMed ID: 25400178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful Treatment With Ustekinumab for Chronic Refractory Pouchitis.
    Tran-Minh ML; Allez M; Gornet JM
    J Crohns Colitis; 2017 Sep; 11(9):1156. PubMed ID: 28199485
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.